Our Team
Leadership Team
Dr. Bo Liu
General ManagerEarned his PhD in Pharmaceutical Sciences from Trinity College Dublin, Ireland, and previously worked as a Research Scientist at Simcyp UK. Research focuses on in vitro simulation of pharmacokinetics and drug metabolism. Independently developed the Virtual Bioequivalence (VBE) platform, supporting 7 successful FDA submissions and approvals. Deployed VBE technology for over 50 generic drug consistency evaluation projects and supported clinical development programs for more than 20 novel drug candidates, with rich industry experience.
Prof. Lihua Xu
Chief AI AdvisorProf. Xu holds a PhD in Computer Science from the University of California, Irvine. Her research outputs have been published at top academic conferences including the International Conference on Software Engineering (ICSE) and Foundations of Software Engineering (FSE). She received the Outstanding New Research Scholar Award at the 2006 Grace Hopper Celebration of Women in Computing.
Dr. Jack Liu
Chief AI Technology OfficerHe obtained his PhD from the University of Connecticut, USA. He leads architecture design and development of the B²O software platform. He previously held senior IT management roles at U.S. financial institutions. He oversees full-lifecycle platform architecture design, evaluation and big data development, as well as foundational infrastructure for AI and big data, with solid expertise in software engineering and cross-functional project delivery.
Shaun Feng
Senior Vice President, Clinical PharmacologyA specialist in quantitative clinical pharmacology with nearly 20 years of experience spanning regulatory authorities (U.S. FDA) and industrial consulting (Certara). She is a pioneer in advancing Model-Informed Drug Development (MIDD) strategies, with a proven track record supporting regulatory submissions covering pre-IND exploratory trials through to New Drug Application (NDA) approvals.
